Pharmaceutical compositions and methods for administering ep2 receptor selective agonists
CA 2468494 A1 · Owner: Kim, Yesook · Inventors: Li, Mei; Thompson, David Duane; Kim, Yesook
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention is directed to pharmaceutical compositions and methods comprising prostglandin agonists, specifically EP2 receptor selective agonists, which are useful to enhance bone repair and healing and restore or augment bone mass in vertebrates, particularly mammals. The EP2 receptor selective agonists of the present invention are effective in the treatment of conditions such as those in which the patient has delayed or non-union fracture, bone defect, spinal fusion, bone in-growth cranial facial , reconstruction or bone sites at risk for fracture.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.